IMM 1.49% 34.0¢ immutep limited

worst corporate governance on the asx, page-69

  1. 2,649 Posts.
    lightbulb Created with Sketch. 249
    Decan

    What, now you are claiming that PRR is not telling the US FDA in its application that it is proposing to conduct CVac Phase III phase trials in the US?

    Wow, misleading holders, ASX, ASIC and now the US FDA. What incredible balls they have!

    That poor Ian Frazer bloke must be cringeing with shame every time he spots his Australian of the Year Award on his desk.

    Have a look at the US FDA site. This link takes you straight to the FAQ and gives you some explanation of FDA provisions concerning Investigational New Drugs.

    http://www.fda.gov/cder/about/smallbiz/faq.htm#Phases%20of%20an%20Investigation

    There is room for overlap between the phases, which is obvious when you read their descriptions. PRR itself announced it as Phase IIb/ III pivotal trial.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.005(1.49%)
Mkt cap ! $493.8M
Open High Low Value Volume
34.0¢ 34.5¢ 32.8¢ $839.2K 2.469M

Buyers (Bids)

No. Vol. Price($)
5 125437 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 85415 6
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.